Mannkind (MNKD) Return on Capital Employed (2011 - 2026)
Mannkind's (MNKD) quarterly Return on Capital Employed came in at 2.34% in Q1 2026, down 2498.0% year-on-year from 0.1% in Q1 2025, and down 71.49% on a QoQ basis from 8.21% in Q4 2025.
Mannkind (MNKD) Return on Capital Employed (2011 - 2026) Analysis & Trends
Mannkind (MNKD) has 16 years of Return on Capital Employed data on file, last reported at 2.34% in Q1 2026.
- On a quarterly basis, Return on Capital Employed fell 2498.0% year-over-year to 2.34% in Q1 2026; TTM through Mar 2026 was 2.34%, a 2498.0% decrease from a year earlier, with the FY2025 full-year figure at 9.19%, down 1139.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 2.34%, down from 8.21% in the prior quarter.
- Over the last five years, Return on Capital Employed for MNKD reached as high as 27.32% in Q1 2025 and fell as low as 32.7% in Q3 2022.
- Historically, Return on Capital Employed has averaged 0.95% across 5 years, with a median of 2.96% in 2023.
- Across the five-year window, Return on Capital Employed surged 3116 bps in 2023 and sank 2498 bps in 2026, its largest moves.
- Year by year, Return on Capital Employed stood at 28.21% in 2022, then soared by 110 bps to 2.96% in 2023, then jumped by 607 bps to 20.91% in 2024, then tumbled by 61 bps to 8.21% in 2025, then sank by 71 bps to 2.34% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 2.34% in Q1 2026, 8.21% in Q4 2025, and 21.21% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn | 2.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.34% |
| Dec 31, 2025 | 8.21% |
| Sep 30, 2025 | 21.21% |
| Jun 30, 2025 | 22.35% |
| Mar 31, 2025 | 27.32% |
| Dec 31, 2024 | 20.91% |
| Sep 30, 2024 | 14.13% |
| Jun 30, 2024 | 12.11% |
| Mar 31, 2024 | 8.30% |
| Dec 31, 2023 | 2.96% |
| Sep 30, 2023 | -5.43% |
| Jun 30, 2023 | -12.78% |
| Mar 31, 2023 | -22.74% |
| Dec 31, 2022 | -28.21% |
| Sep 30, 2022 | -32.70% |
| Jun 30, 2022 | -30.43% |
| Mar 31, 2022 | -23.77% |
| Dec 31, 2021 | -20.33% |
| Sep 30, 2021 | -23.94% |
| Jun 30, 2021 | -21.87% |